3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
5
INDUSTRY
3
Study Type
Observational
3
Sponsor
Cancer Type
Gynecologic
5
NET
4
Endocrine
4
Thoracic
3
Genitourinary
3
Tumor-Agnostic
1
Myeloid
1
CNS
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
542
Pemetrexed
392
pembrolizumab
372
Cisplatin
356
Paclitaxel
285
Docetaxel
240
Gemcitabine
168
Nivolumab
158
Erlotinib Hydrochloride
147
Bevacizumab
114
atezolizumab
104
osimertinib
99
durvalumab
92
Etoposide
90
Gefitinib
68
130-nm albumin-bound paclitaxel
65
Cetuximab
64
Ipilimumab
60
Drug Therapy
51
Topotecan
48
Injections
44
Afatinib
41
tislelizumab
40
Cyclophosphamide
39
Albumin-Bound Paclitaxel
37
Vinorelbine
36
Crizotinib
34
cemiplimab
31
icotinib
26
Radiotherapy
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Data Collection
×
Thoracic
×
Clear all
NCT04994795
2024-11-21
DEEP-Lung-IV
Sophia Genetics SAS
Active not recruiting
4,000 enrolled
NCT02300831
2017-07-14
LUMINIST
AstraZeneca
Completed
770 enrolled
NCT01772225
2014-03-31
LuCaBIS
GlaxoSmithKline
Completed
1 enrolled